Tobam Mirati Therapeutics, Inc. Transaction History

Tobam

  • $328 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$59.5 - $86.7 $3.76 Million - $5.48 Million
63,164 Added 127.0%
112,901 $7.89 Million
Q2 2022

Aug 02, 2022
BUY
$39.16 - $88.71 $1.95 Million - $4.41 Million
49,737 New
49,737 $3.34 Million
Q2 2021

Aug 11, 2021
SELL
$144.0 - $179.73 $23,040 - $28,756
-160 Closed
0 $0
Q4 2020

Feb 03, 2021
BUY
$162.05 - $240.27 $25,928 - $38,443
160 New
160 $35,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Tobam Portfolio

Follow Tobam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email